For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Usual Care | Provider-enhanced usual care arm; no change in asthma management | 4 | None | 74 | 611 | 0 | 611 | View |
| PARTICS | addition of PARTICS strategy - Patient Activated Reliever-Triggered Inhaled CorticoSteroid (PARTICS) using QVAR . Patient will use inhaled corticosteroid at time of rescue inhaler use PARTICS using QVAR: Patient takes inhaled corticosteroid at the time of rescue inhaler use | 3 | None | 75 | 609 | 0 | 609 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Asthma | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Cardiac events | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Gastrointestinal disorders | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Infections and infestations | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Musculoskeletal and connective tissue disorders | NON_SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| Nervous system disorders | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Renal/urinary disorders | NON_SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Reproductive system and breast disorders | NON_SYSTEMATIC_ASSESSMENT | Reproductive system and breast disorders | None | View |
| Skin and subcutaneous tissue disorders | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Substance abuse | NON_SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |
| Vascular disorders | NON_SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| Psychiatric disorders | NON_SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |
| Respiratory, thoracic, mediastinal disorders | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Unclassified elsewhere | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Hematology/oncology | NON_SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Immune system disorders | NON_SYSTEMATIC_ASSESSMENT | Immune system disorders | None | View |
| Metabolism and nutrition disorders | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |